Purpose
The purpose of this study was to evaluate the clinical outcomes of patients treated with radiotherapy (RT) for a carcinoma of the external auditory canal (EAC) and middle ear.
Materials and Methods
The records of 32 patients who received RT from 1990 to 2013 were reviewed retrospectively. The Pittsburgh classification was used to stage all the cancers (early stage, T1/T2 [n=12]; advanced stage, T3/T4 or N positive [n=20]). Twenty-one patients (65.6%) were treated with postoperative RT and 11 patients (34.4%) were treated with definitive RT. The median radiation doses for postoperative and definitive RT were 60 Gy and 64.8 Gy, respectively. Chemotherapy was administered to seven patients (21.9%).
Results
The 5-year overall survival and disease-free survival rates for all patients were 57% and 52%, respectively. The disease control rates for the patients with early stage versus advanced stage carcinomawere 55.6% (5/9) and 50% (6/12) in the postoperative RT group and 66.7% (2/3) and 37.5% (3/8) in the definitive RT group, respectively. Overall, 15 cases (14 patients, 46.7%) experienced treatment failure; these failures were classified as local in four cases, regional in one case, and distant in 10 cases. The median follow-up period after RT was 51 months (range, 7 to 286 months).
Conclusion
Patients with early stage carcinoma achieved better outcomes when definitive RT was used. Advanced stage carcinoma patients experienced better outcomes with postoperative RT. The high rate of distant failure after RT, with or without surgery, reflected the lack of a consensus regarding the best therapeutic approach for treating carcinoma of the EAC and middle ear.
Citations
Citations to this article as recorded by
Survival Outcomes of Temporal Bone Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis Krystelle Sioufi, Aaron David Haynes, Paul W. Gidley, Anastasios Maniakas, Dianna Roberts, Marc‐Elie Nader Otolaryngology–Head and Neck Surgery.2024; 171(1): 1. CrossRef
The international expert consensus on management of external auditory canal carcinoma Pei Zhou, Rubens de Brito, Yong Cui, Simon Lloyd, Henricus Kunst, J. Walter Kutz, Navin Mani, In Seok Moon, Badr Eldin Mostafa, Cindy Nabuurs, Sampath Chandra Prasad Rao, Bingbin Xie, Yibo Zhang, Chunfu Dai European Archives of Oto-Rhino-Laryngology.2024;[Epub] CrossRef
Postoperative Radiotherapy for pT1- and pT2-Classified Squamous Cell Carcinoma of the External Auditory Canal Cindy Nabuurs, Wietske Kievit, Charles Leemans, Conrad Smit, Michiel van den Brekel, Robert Pauw, Bernard van der Laan, Jeroen Jansen, Martin Lacko, Weibel Braunius, Chunfu Dai, Xunbei Shi, Giovanni Danesi, Jan Bouček, Daniele Borsetto, Shravan Gowrishank Cancers.2024; 16(23): 4026. CrossRef
Clinical outcomes of temporal bone squamous cell carcinoma: A single‐institution experience Yongbo Zheng, Ke Qiu, Yangju Fu, Wenjie Yang, Danni Cheng, Yufang Rao, Minzi Mao, Yao Song, Wei Xu, Jianjun Ren, Yu Zhao Cancer Medicine.2023; 12(5): 5304. CrossRef
Analysis of Prognostic Factors For External Auditory Canal Carcinoma: A 22‐Year Experience Isabelle J. H. Jang, Jiun Fong Thong, Constance E. H. Teo, Kiattisa Sommat The Laryngoscope.2023; 133(9): 2203. CrossRef
Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: Expecting Its Application in Temporal Bone Squamous Cell Carcinoma Meng-wen Shi, Jing Huang, Yu Sun Current Medical Science.2023; 43(2): 213. CrossRef
Preoperative simulation using three‐dimensional printer in four temporal bone surgeries Ichiro Fukumoto, Yukiyoshi Mita, Rie Shimmi, Yuri Sonobe, Tomohisa Iinuma, Kazuki Yamasaki, Shuji Yonekura, Toshimitsu Nemoto, Toyoyuki Hanazawa Clinical Case Reports.2023;[Epub] CrossRef
The Efficacy of Radiotherapy without Surgery for External Auditory Canal Squamous Cell Carcinoma Naoto Osu, Atsushi Musha, Hikaru Yumisaki, Kohei Okada, Nobuteru Kubo, Naoko Okano, Yukihiko Takayasu, Masato Shino, Osamu Nikkuni, Shota Ida, Hidemasa Kawamura, Kazuaki Chikamatsu, Tatsuya Ohno Journal of Clinical Medicine.2022; 11(19): 5905. CrossRef
Evaluating the prognostic contributions of TNM classifications and building novel staging schemes for middle ear squamous cell carcinoma Ke Qiu, Wendu Pang, Jianqing Qiu, Junhong Li, Danni Cheng, Yufang Rao, Yijun Dong, Minzi Mao, Qiurui Liu, Xiaosong Mu, Wei Zhang, Wei Xu, Jianjun Ren, Yu Zhao Cancer Medicine.2021; 10(22): 7958. CrossRef
Evaluation of the modified Pittsburgh classification for predicting the disease‐free survival outcome of squamous cell carcinoma of the external auditory canal Cindy H. Nabuurs, Wietske Kievit, Nilou Labbé, C. René Leemans, Conrad F. G. M. Smit, Michiel W. M. van den Brekel, Robert J. Pauw, Bernard F. A. M. van der Laan, Jeroen C. Jansen, Martin Lacko, Weibel W. Braunius, Shinya Morita, Małgorzata Wierzbicka, Ta Head & Neck.2020; 42(12): 3609. CrossRef
Management of Temporal Bone Malignancy in Ireland Robbie S. R. Woods, Anel Naude, John Barry O'Sullivan, Daniel Rawluk, Mohsen Javadpour, Peter Walshe, Peter D. Lacy, James Paul O'Neill, Rory McConn-Walsh Journal of Neurological Surgery Part B: Skull Base.2020; 81(06): 680. CrossRef
A retrospective multicenter study of carbon‐ion radiotherapy for external auditory canal and middle ear carcinomas Kazuhiko Hayashi, Masashi Koto, Yusuke Demizu, Jun‐ichi Saitoh, Hiroaki Suefuji, Tomoaki Okimoto, Tatsuya Ohno, Yoshiyuki Shioyama, Ryo Takagi, Hiroaki Ikawa, Kenji Nemoto, Takashi Nakano, Tadashi Kamada Cancer Medicine.2019; 8(1): 51. CrossRef
Squamous cell carcinoma of the temporal bone: A current review Benjamin D. Lovin, Paul W. Gidley Laryngoscope Investigative Otolaryngology.2019; 4(6): 684. CrossRef
Mucoepidermoid carcinoma in the external auditory canal is extremely rare. Strategies used for treatment of mucoepidermoid carcinoma remain controversial. We present a case of mucoepidermoid carcinoma of the external auditory canal. The patient underwent lateral temporal bone resection and the surgical defect was obliterated with temporal muscle. He is currently disease-free, four years after surgery. Proper diagnostic measures and strategy for treatment of mucoepidermoid carcinoma are discussed.
Citations
Citations to this article as recorded by
Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature Carlo De la Sancha, Matthew Kuhar, Adele Kraft, Ahmed K. Alomari Journal of Cutaneous Pathology.2023; 50(11): 947. CrossRef
Neoplasms of the Ear Canal Mallory Raymond Otolaryngologic Clinics of North America.2023; 56(5): 965. CrossRef
Treatment and survival outcomes of ceruminous carcinomas of the external auditory canal: a SEER database analysis and literature review Brian Wanner, Kyle Rismiller, David R. Carr Archives of Dermatological Research.2022; 314(6): 583. CrossRef
Treatment, Survival, and Demographics in Temporal Bone Malignancies: A Pooled Data Analysis Mitchell R Gore Cureus.2022;[Epub] CrossRef
Ceruminous Neoplasms of the Ear Priyadharsini Nagarajan Head and Neck Pathology.2018; 12(3): 350. CrossRef
Salivary mucoepidermoid carcinoma revisited Andrés Coca-Pelaz, Juan P. Rodrigo, Asterios Triantafyllou, Jennifer L. Hunt, Alessandra Rinaldo, Primož Strojan, Missak Haigentz, William M. Mendenhall, Robert P. Takes, Vincent Vander Poorten, Alfio Ferlito European Archives of Oto-Rhino-Laryngology.2015; 272(4): 799. CrossRef
State of the art in temporal bone malignancies Sampath Chandra Prasad, Flavia D’Orazio, Marimar Medina, Andrea Bacciu, Mario Sanna Current Opinion in Otolaryngology & Head and Neck Surgery.2014; 22(2): 154. CrossRef